Robert J. Mears - Mar 1, 2022 Form 4 Insider Report for Atomera Inc (ATOM)

Role
Chief Technology Officer
Signature
/s/ Mindi Zimmer as Attorney in Fact For: Robert Mears
Stock symbol
ATOM
Transactions as of
Mar 1, 2022
Transactions value $
-$167,946
Form type
4
Date filed
3/3/2022, 03:03 PM
Previous filing
Feb 25, 2022
Next filing
Jun 3, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ATOM Common Stock Options Exercise $70.1K +10K +7.85% $7.01 137K Mar 1, 2022 Direct F1
transaction ATOM Common Stock Sale -$162K -10K -7.28% $16.17 127K Mar 1, 2022 Direct F2
transaction ATOM Common Stock Sale -$8.57K -537 -0.42% $15.95 127K Mar 1, 2022 Direct F3
transaction ATOM Common Stock Sale -$8.87K -556 -0.44% $15.95 126K Mar 1, 2022 Direct F3
transaction ATOM Common Stock Sale -$1.87K -117 -0.09% $15.95 126K Mar 1, 2022 Direct F3
transaction ATOM Common Stock Sale -$14.6K -917 -0.73% $15.95 125K Mar 1, 2022 Direct F3
transaction ATOM Common Stock Sale -$42.4K -2.8K -2.24% $15.15 122K Mar 1, 2022 Direct F2
holding ATOM Common Stock 2.67K Mar 1, 2022 by Spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATOM Employee Stock Option (right to buy) Options Exercise $0 -10K -9.92% $0.00 90.8K Mar 1, 2022 Common Stock 10K $7.01 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option exercise reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and exercised from a previously reported total.
F2 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F3 Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock grants that were previously reported. This sale is to satisfy mandatory non-discretionary tax withholding obligations by a "sell to cover" transaction.